Overview of Moderna’s Investigational RSV Vaccine (mRNA-1345) in Adults ≥ 60 Years of Age

Das, Rituparna

i

Overview of Moderna’s Investigational RSV Vaccine (mRNA-1345) in Adults ≥ 60 Years of Age

Public Domain

February 29, 2024
By Das, Rituparna
Series: ACIP: Respiratory Syncytial Virus (RSV)

File Language:

English

Details

Personal Author:

Das, Rituparna
Corporate Authors:

Moderna (firm)
Description:

The safety and efficacy of this investigational RSV vaccine have not been established in any country for any use

02-RSV-Adults-Das-508.pdf
Subjects:

Adult Respiratory Syncytial Virus Infections/prevention & Control Respiratory Syncytial Virus Vaccines
Series:

ACIP: Respiratory Syncytial Virus (RSV)
Document Type:

Still Image
Name as Subject:

ACIP meeting: 2024 Feb 29 ; ACIP meeting: 2024 Feb 29
Genre:

Presentation ; Conference Publications
Pages in Document:

47 numbered slides
Volume:

202402
Collection(s):

Advisory Committee on Immunization Practices (ACIP)
Main Document Checksum:

urn:sha-512:3644e181344eabf5a4e24c660e081092e631e94c71d134c92042d38eba9befa2c434399de6c328aa6b7f76955f497e5db4e38dd85acb86f16387cdea61deacfb
Download URL:

https://stacks.cdc.gov/view/cdc/148672/cdc_148672_DS1.pdf
File Type:

[PDF - 1.19 MB ]

File Language:

English

ON THIS PAGE

Details Related Documents

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.